JW Lifescience said its second-quarter operating profit rose 3.76 percent year-on-year to 7.84 billion won ($5.54 million) on a separate basis, according to a regulatory filing Wednesday.

Revenue for the same period fell 0.8 percent to 56.73 billion won.

Net profit for the period came in at 5.95 billion won, down 37.23 percent, according to preliminary figures.


jiyoon436@heraldcorp.com